Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Niagen Bioscience, Inc. | 62,131 | reported | 19 Feb 2026 | tx 6+235,497.6 |
| ETHZilla Corp | 15,000 | reported | 04 Sept 2023 | tx 4+203,962.08 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Niagen Bioscience, Inc. | 62,131 | 0.00 USD | deriv |
| 14 Nov 2025 | PURCHASE | Niagen Bioscience, Inc. | 4,464.96 | 6.81 USD | |
| 14 Nov 2025 | PURCHASE | Niagen Bioscience, Inc. | 2,220.44 | 6.85 USD | |
| 12 Feb 2025 | GRANT_AWARD | Niagen Bioscience, Inc. | 17,230 | 0.00 USD | deriv |
| 22 Nov 2024 | PURCHASE | Niagen Bioscience, Inc. | 2,907.2 | 7.36 USD | first after silence |
| 21 Oct 2024 | GRANT_AWARD | Niagen Bioscience, Inc. | 146,544 | 0.00 USD | deriv |
| 04 Sept 2023 | GRANT_AWARD | ETHZilla Corp | 15,000 | 0.00 USD | deriv |
| 18 May 2023 | PURCHASE | ETHZilla Corp | 5,162.08 | 1.01 USD | first after silence |
| 10 Dec 2021 | PURCHASE | ETHZilla Corp | 3,800 | 3.87 USD | |
| 26 Feb 2021 | GRANT_AWARD | ETHZilla Corp | 180,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 22 Nov 2024.